Follicle stimulating hormone biosimilar (Amega Biotech)

促卵泡激素生物类似药 (Amega Biotech)

Report date: 2022/03/04 16:16:37

Base Information

Drug NameFollicle stimulating hormone biosimilar (Amega Biotech)

Drug Alias Name促卵泡激素生物仿制药 (Amega Biotech)

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone

Mechanisms of ActionFollicle-stimulating hormone receptor agonists

TargetsFollicle-stimulating hormone receptor

Therapy Area/IndicationsInfertility, FemaleInfertility, Male

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmega Biotech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmega Biotech

Active IndicationsN/A

Inactive IndicationsInfertility, FemaleInfertility, Male

ATC CodeN/A